Qizheng is fully committed to researching and promoting the academic value of Tibetan medicine.

　　“Compared with Western medicine, traditional Chinese medicine is relatively difficult for the public to understand and accept; and compared with Chinese herbal medicine, Tibetan medicine is even more challenging to get people to accept and use,” Feng Ping, vice president of Tibet Qizheng Tibetan Medicine Co., Ltd., told reporters recently at the “Getting Close to Modern Tibetan Medicine” event held in Yuzhong County, Gansu Province. Although the path toward modernization of ethnic medicines is fraught with difficulties, Qizheng Tibetan Medicine will remain committed to promoting its academic value through modern theoretical research and enhancing the influence of Tibetan medicine in the mainstream pharmaceutical market.

　　Through research based on traditional theories, Qizheng Tibetan Medicine has uncovered new markets, applications, and directions for traditional Tibetan medicines. For example, by studying the Tibetan medical theory of “white-pulse disease,” the traditional Tibetan medicine “White-Pulse Ointment” has been extended into the modern field of rehabilitation, with clinical studies on stroke-induced limb-function recovery being conducted at 18 major hospitals across China. Furthermore, in-depth research on the Tibetan medical theory of “yellow-water disease” has revealed that Qingpeng Ointment—originally used to treat musculoskeletal disorders associated with “yellow-water disease”—also proves effective in treating eczema. Today, it has become the best-selling Tibetan medicine (including Chinese herbal medicines) in China’s dermatology market.

　　Qizheng leverages innovation as its driving force to promote the company’s sustainable development. It has, for the first time both domestically and internationally, uncovered a novel neurobiological mechanism underlying the transdermal analgesic effects of traditional medicines. This discovery sheds light on the mechanisms of action behind external therapeutic methods used in Tibetan medicine and Traditional Chinese Medicine, such as moxibustion, fire moxibustion, heavenly moxibustion, cupping, and guasha. More than ten evidence-based studies on Qizheng Xiaotong Paste represent the variety with the most robust evidence and the most extensive basic research among China’s traditional topical medications currently available. Clinical evidence for Honghua Ruyi Pills has been incorporated into the “Guidelines for Diagnosis and Treatment of Pelvic Inflammatory Disease” issued by the Obstetrics and Gynecology Branch of the Chinese Medical Association. The Qingpeng Ointment has completed the first randomized, double-blind, placebo-controlled trial ever conducted on Tibetan medicine, and has been included in the “Expert Consensus on the Use of Traditional Chinese Medicines for the Treatment of Eczema and Dermatitis” published by the Chinese Society of Integrated Traditional and Western Medicine.

　　Traditional cultural marketing represents a convenient and efficient approach to promoting ethnic medicines in the market. However, Feng Ping points out that Qizheng Tibetan Medicine has chosen an academic promotion strategy that places great emphasis on science and clinical efficacy. In 2015 alone, the company conducted nearly 500 academic promotion events and workshops on interpreting grassroots clinical guidelines. By combining “brand-driven” and “academically driven” approaches, Qizheng Tibetan Medicine has established a specialized marketing system featuring a three-pronged division of labor among major hospitals, retail outlets, and primary-care facilities. “Culture permeates subtly and silently; human rights and respect are paramount—never lightly claim that you’re providing assistance.” Lei Jufang, Chairwoman of Qizheng Tibetan Medicine, has truly integrated the inheritance and protection of Tibetan traditional culture into her very being, forging it into the core values of the company: pursuing goodness, staying true to one’s path, and conducting business with integrity.

　　According to what our reporter has learned, Qizheng Tibetan Medicine is currently the leading enterprise in China’s modern Tibetan medicine sector. Its products, such as the Xiaotong Paste, have demonstrated remarkable efficacy and continue to enjoy strong sales in the pharmaceutical market. As of the end of 2015, the company’s total assets amounted to 2.07 billion yuan.

　　Media Report: China National Journal of Traditional Chinese Medicine

　　Report link: http://mp.weixin.qq.com/s?__biz=MzI3MzE1MzQ4Ng==&mid=2650916602&idx=5&sn=d418c426f458aefc4e5a20c042272597&chksm=f0d2ca5bc7a5434d8ed150c5703846790d9a080ca4e7dd539099978f1217fedf1100506df955&mpshare=1&scene=1&srcid=100